VTGN financials
Vistagen Therapeutics (VTGN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- VTGN revenue was $1.27M in fiscal 2026, net income -$69.69M.
VTGN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $1.27M | – | -$72.13M | -$69.69M | -1.83 |
| 2025 | $486.00K | – | -$55.97M | -$51.42M | -1.67 |
| 2024 | $1.06M | – | -$33.02M | -$29.36M | -1.52 |
| 2023 | – | – | -$59.27M | -$59.25M | -8.51 |
| 2022 | $1.11M | – | -$47.78M | -$48.71M | -7.38 |
| 2021 | $1.09M | – | -$17.93M | -$42.32M | -0.49 |